RecruitingNCT05734404
Longitudinal Study for Central Nervous System Vasculitis
Sponsor
University of Pennsylvania
Enrollment
40 participants
Start Date
Mar 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- i. Diagnostic criteria for CNSV
- The presence of an acquired and otherwise unexplained neurologic deficit
- The presence of either classic angiographic or histopathologic features of angiitis in the CNS
- No evidence of systemic vasculitis or any condition that could cause the angiographic or pathologic features
- ii. ≥18 years of age
Exclusion Criteria1
- i. Unwilling to sign informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05734404
Related Trials
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
NCT026387011 location
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT0632160132 locations
SysteMic vAsculitis pRognosis and ouTcome
NCT075861371 location
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
NCT072786091 location
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
NCT050120331 location